- Home
- CASI vs CGBS Comparison
CASI vs CGBS Comparison
Compare CASI & CGBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CASI
- CGBS
- Stock Information
- Founded
- CASI 1991
- CGBS 2018
- Country
- CASI China
- CGBS Jersey
- Employees
- CASI N/A
- CGBS N/A
- Industry
- CASI Biotechnology: Pharmaceutical Preparations
- CGBS
- Sector
- CASI Health Care
- CGBS
- Exchange
- CASI Nasdaq
- CGBS Nasdaq
- Market Cap
- CASI 29.0M
- CGBS 30.9M
- IPO Year
- CASI 1996
- CGBS N/A
- Fundamental
- Price
- CASI $1.33
- CGBS $0.09
- Analyst Decision
- CASI Strong Buy
- CGBS
- Analyst Count
- CASI 1
- CGBS 0
- Target Price
- CASI $4.00
- CGBS N/A
- AVG Volume (30 Days)
- CASI 287.9K
- CGBS 85.5M
- Earning Date
- CASI 08-15-2025
- CGBS 01-01-0001
- Dividend Yield
- CASI N/A
- CGBS N/A
- EPS Growth
- CASI N/A
- CGBS N/A
- EPS
- CASI N/A
- CGBS N/A
- Revenue
- CASI $31,368,000.00
- CGBS N/A
- Revenue This Year
- CASI N/A
- CGBS N/A
- Revenue Next Year
- CASI N/A
- CGBS N/A
- P/E Ratio
- CASI N/A
- CGBS N/A
- Revenue Growth
- CASI 8.39
- CGBS N/A
- 52 Week Low
- CASI $1.10
- CGBS $0.06
- 52 Week High
- CASI $7.67
- CGBS $6.91
- Technical
- Relative Strength Index (RSI)
- CASI 28.60
- CGBS N/A
- Support Level
- CASI $1.10
- CGBS N/A
- Resistance Level
- CASI $2.07
- CGBS N/A
- Average True Range (ATR)
- CASI 0.28
- CGBS 0.00
- MACD
- CASI -0.06
- CGBS 0.00
- Stochastic Oscillator
- CASI 12.36
- CGBS 0.00
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.
About CGBS Crown LNG Holdings Limited Ordinary Shares
Crown LNG Holdings Ltd is an LNG infrastructure company that seeks to provide natural gas liquefaction, storage, and re-gasification services. It focuses on enabling a stable and reliable supply of LNG to customers, especially in geographic areas where onshore or floating facilities may be difficult or less desirable as a result of harsh weather conditions, safety or environmental concerns, or cost. It specializes in the design and operation of offshore, all-weather LNG liquefication and re-gasification terminals, such as gravity-based structures. Through Its technologies and design, It believes it can deliver tailored LNG infrastructure suitable for energy-isolated locations, as well as provide critical LNG infrastructure to under-served markets around the world.